JN
Therapeutic Areas
Aethlon Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Hemopurifier® | Solid Tumors (adjunct to anti-PD-1 therapy) | Early Feasibility / Safety |
Leadership Team at Aethlon Medical
JB
James B. Frakes
Chief Executive Officer and Chief Financial Officer
SL
Steven LaRosa, M.D.
Chief Medical Officer
MB
Michele Bombardiere
Vice President, Controller
EG
Edward G. Broenniman
Chairman of the Board
AR
Angela Rossetti
Director
CS
Chetan S. Shah, M.D.
Director
NG
Nicolas Gikakis
Director